Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically
Emily K. Wright(Brigham and Women's Hospital), Thierry Dervieux(Prometheus Biosciences (United States))
Cited by 16
Related Papers
Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography
|Journal of Crohn s and Colitis|2020|62
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero
|Clinical Gastroenterology and Hepatology|2024|23
Reliability of Intestinal Ultrasound for Evaluating Crohn’s Disease Activity Using Point-of-care and Central Reading
|Clinical Gastroenterology and Hepatology|2024|22